The European Innovation Council is a European Union institution that funds and accelerates deep-tech innovation across Europe. It provides substantial support to startups, researchers, and technology transfer activities through programs such as the EIC Accelerator, EIC Fund, and EIC Prizes, and offers business acceleration services to help scale and globally expand ventures. The council is described as a major investor, providing about €6.5 billion in funding, and it co-invests with private investors in early-stage startups with ESG impacts. Established in 2018 and headquartered in Brussels, it focuses on breakthrough innovations in deep technology, including dual-use and defence-relevant technologies, and engages with innovation ecosystems through events, reports, and information hubs. The organization is oriented toward advancing European competitiveness by nurturing high-potential tech ventures from inception through scaleup.

Innogest Capital is an Italian venture capital firm founded in the mid-2000s that backs early-stage technology and healthcare startups. It maintains offices in Turin and Milan, with a global footprint that includes San Francisco and Geneva. The firm collaborates with local and international research centers and technology transfer offices to support portfolio companies. Its investment focus spans medical devices, diagnostics, and digital health within healthcare, and digital verticals such as foodtech, fintech, fashion-tech and lifestyle in the technology sector. It emphasizes building sustainable, ESG-compliant businesses and leverages a broad network to help entrepreneurs scale, commercialize innovations and access strategic partnerships. Through its networks, Innogest Capital seeks to foster innovation across Europe and beyond while maintaining an early-stage investment approach.

Veris Ventures is a venture capital firm founded in 2022 and based in Geneva and Luxembourg. It is an early-stage investor focused on blockchain technology, with investments in cryptocurrency, blockchain startup companies, and Internet of Things applications.

4See Ventures is a Swiss venture capital firm based in Geneva that backs early-stage startups in healthcare, biotech, medtech, technology, sustainability and climate tech. Founded in 2019, the firm concentrates on Swiss ventures with game-changing potential, emphasizing disruptive innovation, market insight, and anticipation of future trends. It supports entrepreneurs who drive societal impact and transformation, and has invested in companies such as Haya Therapeutics, Transmutex, Distalmotion, and Goodwall.

F2 Ventures is a healthcare investment platform and venture capital firm focused on biotechnology arbitrage opportunities. Based in London and Geneva, the firm targets innovative biotechnology companies at pivotal stages to maximize impact and portfolio value. The organization operates in the United Kingdom and pursues opportunities across the biotech sector, with emphasis on strategic timing and value creation.

Medicxi is a venture capital firm focused on the life sciences sector. Founded in 2016 by the former Index Ventures life sciences team, the firm is based in London, United Kingdom, with additional offices in Geneva and Jersey. Medicxi invests across seed, early, and later stages in Europe, targeting therapeutics, biotech, and technology-enabled healthcare companies. Building on decades of experience in drug discovery and development, the team supports ventures across a broad range of therapeutic areas, including vaccines, oncology, and neurology, helping firms advance research, development, and commercialization. The firm originated from Index Ventures and continues to back ambitious startups seeking to translate scientific advances into patient benefit, leveraging a hands-on approach and a network of biopharma partnerships.

Tayssir Capital is a Geneva-based venture capital firm, established in 2021, that specializes in digital assets investments. The company focuses on identifying and funding opportunities in the digital asset space from its Geneva base, aiming to support early-stage and growth ventures with capital and strategic guidance.

Vinci Capital is a Swiss venture capital and private equity firm focused on mid to late venture, succession financing, owner- and management buyouts, spin-offs or carve-outs, and secondary share-backs. It invests in Swiss technology and industrial companies, typically committing CHF 7–10 million per portfolio and targeting firms with annual sales of roughly CHF 20–80 million. The firm seeks opportunities in new media technologies and services, life sciences, microelectronics and nanotechnology, and software and e-Business, and it often takes board seats and can syndicate larger rounds. Founded in 2003 and headquartered in Geneva with an office in Zug, Vinci Capital operates as a subsidiary of Vinci Partners.

Alpana Ventures is a Geneva-based Swiss venture capital firm focused on digital transformation and deep tech. Founded in 2016, it backs founder teams across Europe, Switzerland, and the United States, investing from early stages to growth in sectors such as healthcare, information technology, finance, enterprise software, mobility, cybersecurity, AI, robotics, and cloud gaming. The firm seeks to embed innovative technologies into new or evolving business models to help portfolio companies become global market leaders, and it applies ESG criteria to support sustainable outcomes.

French Partners is a venture capital organization and the first co-investment club for qualified investors who support French entrepreneurs internationally. It targets growth-stage startups and SMEs with revenues up to tens of millions of euros and invests typically 1 to 5 million euros per deal, usually as minority stakes, either solo or in co-investment with other funds. The firm relies on a network of serial entrepreneurs and sectoral experts who provide capital and hands-on guidance to help founders scale globally. It embraces the French Diaspora and focuses on international development where the entrepreneur resides, with a francophone network across France and continents including the United States and China. Based in Geneva, Switzerland, French Partners aims to offer access and guidance beyond funding to accelerate international growth.

Alta Berkeley is a London-based venture capital firm founded in 1982 that specializes in early-stage technology investments across Europe, Israel and the United States. The firm backs seed and startup opportunities with a focus on high-technology sectors including software, semiconductor, communication and computing technologies, and medical technology. It typically invests in initial rounds around 1.5 to 3 million pounds and increases to roughly 4 to 8 million as companies advance, often taking a lead role while also co-investing in syndicates. The firm supports portfolio companies through growth and strategic development with an emphasis on helping early-stage ventures scale. Exits are pursued through public offerings, acquisitions or trade sales in the United States and Europe. Alta Berkeley maintains a London headquarters and has had an additional office in Geneva, reflecting a cross-border approach to backing technology ventures. The firm seeks to build value by combining operational guidance with sector expertise to help portfolio companies mature toward scalable commercial success.

DAA Capital Partners is a Swiss-based investment firm headquartered in Geneva that specializes in European logistics real estate, with a focus on urban distribution centers and last-mile and light-industrial properties along key logistics corridors. The firm emphasizes strategic asset management, including refurbishment and ESG upgrades, to meet evolving tenant needs. It operates from Geneva with offices in Luxembourg and conducts activities through DAA Ventures.

Climb Ventures is a Swiss venture capital firm founded in 2020 and based in Geneva. It backs technology-focused startups across Europe, investing in sectors such as information technology, IoT, advanced manufacturing, fintech, AR, clean tech, e-commerce, gaming, and agtech, with particular attention to Swiss companies pursuing global scale. The firm provides capital, strategic guidance, and access to industry networks to accelerate growth and international expansion, including AI, renewable energy, and digital transformation. Climb targets founders with global ambitions and supports growth to late-stage across digital services, consumer internet, and emerging technologies, leveraging a European footprint to drive market penetration.

BNVT Capital is a global venture capital firm headquartered in London with a multi-regional footprint including New York and Riyadh. Founded in 2023 by former investors from the Gates Foundation, Hedosophia, and Goldman Sachs, the firm pursues an investment approach called Benevolent Disruption, guided by proprietary returns data to back startups that address large, systemic problems with substantial market potential.

Lowercarbon Capital is a Los Angeles-based venture capital firm that supports climate technology companies across energy, advanced manufacturing and climate resilience. It backs startups from early stages to scale real-world solutions in areas such as carbon capture, renewable energy, sustainable transportation and alternative materials, prioritizing ambitious scientific approaches coupled with commercially viable outcomes. The firm provides hands-on support to portfolio companies and cultivates an ecosystem of founders and industry experts to accelerate the transition to a low-carbon economy, having invested over $200 million across multiple rounds.

MMC Ventures is a London-based venture capital firm that backs early-stage technology companies at seed and Series A, with a focus on enterprise AI, fintech, data-driven health, data infrastructure, and cloud. The firm pursues a research-led approach, aiming to understand each portfolio company’s underlying technology and business model to inform its decisions and support. Beyond capital, MMC Ventures provides founder-focused assistance, including sales introductions and talent support through its MMC CONNECT platform. While its investments span Europe, the firm concentrates on UK opportunities and seeks to be a hands-on partner in building sustainable growth for its portfolio companies.

Earthshot Ventures is a San Francisco-based venture capital firm that invests in early-stage companies across AI, infrastructure, energy, and critical minerals. It focuses on Pre-Seed to Series B opportunities worldwide, backing technologies that enable a faster, cheaper, and more sustainable AI economy, including compute efficiency, clean energy, and robust mineral supply chains. The firm targets startups building the materials, power, and compute infrastructure essential to the AI era and aims to help them scale toward large markets and clear impact. It is co-managed with Launch Alaska and emphasizes commercialization and execution to support meaningful climate and economic outcomes.

VI Partners is a Swiss venture capital firm focused on healthcare and technology. Founded in 2001, it supports university spin-offs and other promising start-ups with capital, coaching and networks to help bring innovative ideas to market. Based in Altendorf, the firm invests in high-growth healthcare, biotechnology, technology and software companies across Switzerland and Europe, partnering with founders to scale early-stage ventures and translate scientific advances into commercial products. VI Partners emphasizes bridging academia and industry, leveraging its networks to accelerate development and commercialization for portfolio companies.

Omega Funds is a Boston-based venture capital firm founded in 2004 that focuses on investing in life sciences and related technologies. The firm targets opportunities in healthcare and biotech, including digital health, immunology, rare diseases, precision medicine, oncology, cybersecurity, and software-as-a-service, with activity across North America and Western Europe. Omega Funds acts as a registered investment adviser, supporting early-stage and growth companies as they develop therapeutic and digital health solutions.

Helsinn Healthcare is a leading cancer care company focused on improving the health and quality of life of people with cancer. It develops, licenses and commercializes oncology products and cancer supportive care therapies, while supplying active pharmaceutical ingredients and finished dosage forms. The company works on medical compounds across oncology, supportive care, pain, inflammation and gastrointestinal areas, with attention to reducing adverse effects of cancer treatment. Its portfolio covers late- and commercial-stage products and aims to bring innovative solutions to patients worldwide, supported by rigorous manufacturing standards and a commitment to addressing unmet patient needs, including rare diseases.

DART Ventures is a Zurich-based venture capital firm established in 2017 that invests in early‑stage B2B technology startups in health, climate, and related sectors across the United States and Europe. It backs Swiss and European teams developing breakthrough solutions in health technology, health consumer tech, food technology, and clean technology, and provides a 12‑month expansion program offering guidance on strategy, culture, fundraising, and go‑to‑market, supported by a network of experienced partners. The firm emphasizes founders and pursues the belief that purpose and profit together drive meaningful impact, with a focus on helping startups succeed in the US market through tailored support and market access.

CDP Venture Capital is a leading Italian venture capital fund manager that oversees about €4.9 billion in assets under management across 15 direct and indirect funds. The firm concentrates its investments in sectors integral to Italy’s growth, aiming to place entrepreneurship at the center of economic development. It supports a mature portfolio, pursues ecosystem collaborations to strengthen investments and innovation, and is expanding through new vehicles such as Ulixes and Lumen Ventures' Lumen II, a seed-stage fund focused on insurtech, fintech, digital health, and cybersecurity. CDP maintains a substantial presence in Rome and Milan and offers opportunities through programs like XJOBS. The organization emphasizes transparency through regular investor materials and annual reports, reinforcing its role in advancing the venture capital ecosystem in Italy.

Union Square Ventures is a New York-based venture capital firm founded in 2003 that focuses on early-stage to growth-stage internet companies. It concentrates on the applications layer of the web, internet services, and web services that create large networks, with emphasis on businesses that generate network effects across sectors such as social media, marketplaces, developer tools, learning, health, fintech, web3 and decentralized systems, technology, and climate. The firm typically makes initial investments around 1 million dollars and can participate in larger rounds up to about 20 million dollars, often taking a lead role and working closely with founders to support growth. It pursues investments across major markets globally, including New York, San Francisco, London, and Berlin.

Presight Capital is a venture capital firm founded in 2019 and based in San Francisco, California. It invests in a wide range of sectors, including biotechnology, software as a service, information technology, telecommunications and media, consumer, fintech, cybersecurity, food tech, cryptocurrency, and healthcare, and it supports founders across different stages and geographies.

Nauta Capital is a European venture capital firm headquartered in London, with offices in Barcelona and Munich. Founded in 2004, it invests in early-stage B2B software, enterprise technology, and deep technology companies across Europe.

Nina Capital is an international venture capital firm based in Barcelona, Spain, specializing in healthcare transformation powered by information technology. Founded in 2019, the firm focuses on early-stage investments from pre-seed to seed+ led by need-driven founders, supported by data and computing resources. Its diverse, multinational team is formed by former healthcare technology founders and operators with deep experience across healthcare and tech sectors. Since inception, Nina Capital has invested in numerous health-tech companies across multiple regions, aiming to improve patient outcomes worldwide. The firm explicitly excludes investments in drugs and vaccines.

Serpentine Ventures is the venture capital arm of the Swiss Ventures Group, based in Zurich, Switzerland. Founded in 2019, it concentrates on European information technology and software-as-a-service investments, providing early and growth funding to promising technology companies. The firm supports founding teams with strategic guidance and operational input while leveraging the Swiss group's networks to help portfolio companies scale. As an arm of a broader Swiss startup ecosystem, Serpentine Ventures aims to back ventures with strong tech propositions and scalable business models across the European market.

Syncona is a London-based life sciences investment company that builds and supports businesses developing treatments for serious diseases. It focuses on areas including gene and cell therapy, and works with scientific teams to advance innovative treatments for patients with significant unmet needs. Syncona invests globally.

ACE & Company is a global private equity and venture capital firm founded in 2005, with over 20 years of experience and more than $2 billion in assets under management. It operates through ACE Ventures, a global venture capital arm focused on early to late‑stage technology companies, and ACE Private Equity, which concentrates on lower mid‑market buyouts and secondary investments. The firm pursues opportunities across private markets with a sector‑ and region‑agnostic approach and maintains a global footprint with offices in Geneva, Zurich, New York, London, and Cairo. ACE emphasizes disciplined execution and risk management to capture opportunities, supported by specialized investment teams and, where appropriate, partnerships with external specialists to deliver opportunities and independent analysis.

Gaingels is a venture investment syndicate focused on supporting LGBTQ+ founders and leaders, investing in companies across stages and sectors and prioritizing inclusive teams and governance. It operates a global portfolio of companies and provides capital alongside resources to recruit diverse talent for C-suite and board roles. The network emphasizes collaboration among investors, operators, and entrepreneurs to advance positive social change through business.

Amboy Street Ventures is a Los Angeles-based venture capital firm founded in 2021 that concentrates on early-stage investments in women’s health and sexual wellness technology. The firm backs seed and Series A rounds for startups addressing fertility, menopause, maternal health, menstrual health, hormonal health, contraception, and broader sexual health and wellbeing, with activity across the United States and Europe. Its portfolio emphasizes inclusive solutions spanning all genders and aims to accelerate innovation in a substantial, multisector market by supporting companies that improve health outcomes and access in women’s health and sexual wellbeing.

Founded in 2022, House Of Ventures is an investment and advisory firm serving next-generation investors. It connects capital with venture opportunities, particularly in technology, and offers education, networking, and support to investors and portfolio companies. Sources identify Los Angeles and San Francisco as its base locations.

At One Ventures is a San Francisco-based venture capital firm that backs early-stage companies using deep technology to reduce environmental harm or restore nature. It invests in areas including energy, food and agriculture, clean technology, and solutions for air, water, soil, and biodiversity.

Hardware Club is a venture capital firm that targets seed-stage investments in hardware and hardtech companies, providing capital and an ecosystem of resources to founders. Headquartered in Paris with a global reach, it engages with startups across the United States and Europe and maintains a community of more than 500 startups, offering partnerships and events to help scale businesses in areas such as digital health, artificial intelligence, sensors, connected devices, smart buildings, and related hardware-enabled technologies.

Tiny Supercomputer Investment Company is a venture capital firm focused on early-stage technology startups in Europe. Since 2017 it has invested roughly 200-250k in pre-seed and seed rounds, primarily from bases in London with a presence in Berlin. The firm operates as a supportive partner, avoiding board seats and not leading rounds, and it collaborates with founders through a community of over 900 founders to help navigate investor relations, problem-solving and decision-making. The team comprises experienced partners specializing in investing, fundraising, operations and legal, enabling strategic guidance and practical support throughout the early growth stages.

Index Ventures is a venture capital firm with offices in London, San Francisco, and Geneva that backs technology companies across sectors such as software, fintech, healthcare, AI, data, and consumer technology. It provides capital and strategic support to early-stage and growth-stage startups, helping teams refine business models, scale operations, and pursue expansion. The firm conducts due diligence, structures financing, and leverages a global network to connect founders with opportunities, customers, and investors. Since its founding in 1996, Index has partnered with entrepreneurs to turn bold ideas into global businesses and to advance market entry and scale across geographies.

Broadhaven Ventures is a fintech-focused investment company that also operates as a branding and web studio. It invests its own capital in fintech startups and remains engaged with portfolio companies beyond the initial round, providing strategic and operational support alongside branding, design, and product development services. The firm collaborates with banks, fintechs, and financial services players to accelerate innovation and drive market structure evolutions, emphasizing robust financial infrastructure and customer-focused concepts. Through its combined investment and creative services, Broadhaven seeks to build and scale market leaders across consumer and enterprise fintech sectors.

LIFTT is a Europe-based venture capital holding founded in 2019 and focused on deep-tech investments across multiple verticals, including human health and aging, critical resources, infrastructure for the data revolution, energy security, and industrial automation. Based in Turin, Italy, the firm acts as a catalyst to translate advanced scientific research into high-impact companies by connecting ideas, talent, territories and financial resources, pursuing an active, multi-vertical approach to foster innovation across Europe and beyond.

Panakes Partners is an independent venture capital firm based in Milan, Italy, focused on early-stage investments in life sciences and healthcare across Europe and Israel. Founded in 2015, it backs ambitious teams developing innovative therapies and technologies with the goal of improving patient outcomes. The firm emphasizes partnering with portfolio companies through its extensive network of clinicians and industry experts, providing strategic guidance and operational support to accelerate development across therapeutic areas such as dermatology, surgery, ophthalmology, cardiology, oncology, biotechnology, and neurostimulation.

OCCIDENT is a Munich- and Zug-based venture capital firm that backs deep-tech start-ups and spin-offs from scientific research. It invests its own capital from the seed stage and provides long-term, hands-on support in life sciences and industrial tech, combining financial backing with extensive experience to help teams translate breakthroughs into scalable solutions. The firm operates with an owner-managed structure and emphasizes a science-driven approach and close collaboration with founders to pursue sustainable growth and societal impact. Its portfolio has included notable momentum, such as Tubulis, acquired by Gilead in 2026, and Immitra Bio, which raised early-stage funding in 2026, reflecting a focus on transformative technologies.

EMURGO is a blockchain company focused on commercial adoption of Cardano's technology. It acts as the official commercial and venture arm of the Cardano project, collaborating with IOHK to grow the Cardano ecosystem globally. EMURGO provides R&D expertise, supports ventures through investments and advising, and develops solutions across tokenization, fintech, and Web3 for enterprises, developers, startups, governments, and other participants. The company emphasizes connecting digital assets with fiat, enabling economic growth and innovation within Cardano's ecosystem, and operates through regional entities including EMURGO MEA to expand its global reach. It also supports Cardano-related startups via EMURGO Ventures, a venture arm that funds early and growth-stage companies in blockchain, fintech, and Web3 industries.

Velocity Ventures is a Singapore-based venture capital firm investing globally in travel and hospitality technology, with a focus on travel services, transportation, accommodations, experiences and food and beverage sectors, including activity in the APAC region. The team combines travel and hospitality sector specialists with seasoned entrepreneurs, bringing over a century of combined experience to help seed to Series A startups grow. The firm emphasizes value-added support beyond traditional VC and pursues partnerships with governments, accelerators, and corporates to strengthen the ecosystem. Its portfolio includes TripGuru, illustrating growth under its backing, and it has published a 2026 annual report detailing progress and strategic plans.

Aisling Capital is a New York-based venture capital and private equity firm founded in 2000 that specializes in healthcare and life sciences. The firm backs late-stage and growth companies developing innovative therapeutics, diagnostics, and medical technologies across the United States, Canada, and Western Europe, with a focus on advancing products to commercialization. Its portfolio has included companies across areas such as biotechnology, neuroscience, and regenerative medicine, and it seeks to support companies through capital and strategic guidance to translate scientific breakthroughs into patient care.

Torsa Capital is a venture capital firm based in Gijón, Spain, founded in 2006. It aims to create value in its investee companies by supporting management teams with solid business models through an active, hands-on partnership. The firm operates a diversified platform across sectors such as commercial services, transportation, food, education, healthcare, information technology, industrials, manufacturing, technology, telecommunications and mobile, with a focus on opportunities in Spain. Its approach combines experienced governance with hands-on collaboration to help portfolio companies scale and improve performance.

New Enterprise Associates is a venture capital firm headquartered in Menlo Park, California. Founded in 1977, it invests in technology and healthcare companies from seed stage through later growth and public offerings, and provides founders with operational and strategic support. Its investments span areas including software, consumer technology, life sciences, biotechnology, medical devices, and energy technology. The firm operates across the United States, Asia, and Brazil, with offices in the United States, India, and China.

Next Ventures is a venture capital firm with a global footprint, supporting early-stage and growth-capital investments in health, wellness, sports, fitness, and technology. Based in North America and Europe, it backs startups that advance whole-person care, clinical intelligence, telehealth, wearables, and AI-driven health delivery, as well as technology-enabled services across finance technology, biotech, and digital platforms. The firm seeks to create value through hands-on portfolio support and strategic partnerships, aiming to improve health outcomes while reducing costs and capturing growth in the sports, nutrition, and wellness markets. Its international activity covers markets in the United States and United Kingdom, among others, reflecting a broad, cross-sector approach to innovative solutions that connect health, technology, and consumer wellness.

Sofinnova Investments is a venture capital firm founded in 1976 and based in Menlo Park, California, with offices in La Jolla, Montreal and Tokyo. It focuses on seed through early-stage investments and selected later-stage opportunities in life sciences and information technology across the United States and Europe. In life sciences, it backs clinical-stage pharmaceutical products, biotechnology, biopharmaceuticals, therapeutic drugs and medical technology platforms addressing unmet medical needs, with initial investments typically in the low millions and total commitments in the tens of millions; the firm often requires a board seat when leading or co-leading early rounds. In information technology, it supports product-oriented IT, enterprise software, service-provider software and telecommunications infrastructure across development stages. Sofinnova collaborates with entrepreneurs to secure initial funding, build teams, win customers and navigate acquisitions and IPOs, leveraging domain expertise to help portfolio companies scale globally. It does not invest in healthcare services, diagnostics, nutraceuticals or tool-kit ventures.

LGT Capital Partners is a global alternative investment manager headquartered in Pfaeffikon, Switzerland. Founded in the 1990s, the firm specializes in private markets and liquid alternatives, offering debt and equity oriented strategies across buyouts, venture capital, real estate, growth capital, and hedge funds, as well as specialized long-only and multi-asset solutions. It serves institutional investors such as pension funds, sovereign wealth funds, foundations, endowments, banks, and other clients through customized programs and separate accounts, often investing alongside clients to align interests. With offices in major markets worldwide, the firm employs a research-driven approach to manager selection and risk management across public and private market strategies, including private equity, hedge funds, real estate, and commodities, and emphasizes sustainable investing and long-term partnerships.

TeleSoft Partners is a venture capital firm founded in 1996 that concentrates on technology, communications, and energy value chain companies in North America. It provides value-added capital along with knowledge, contacts, and hands-on expertise to help entrepreneurs grow and achieve exits. The firm has a track record of supporting portfolio companies toward mergers, acquisitions and initial public offerings, contributing to the growth of numerous technology and energy ventures.

Paradigm is a venture capital firm and software development company focused on pioneering technologies across cryptocurrency, artificial intelligence, robotics, and other emerging fields. Founded in 2018 and based in San Francisco, the firm backs unconventional founders at every stage, providing capital and strategic guidance while combining technical research with hands-on support to advance product development. It collaborates with builders early in projects and emphasizes open-source software development. Paradigm invests globally across sectors and has backed category-defining companies and protocols that reshape how people transact, build, and compute. The firm maintains offices in San Francisco, New York, and Washington, D.C., and expands its impact through fellowships and opportunities for researchers and engineers working at frontier technologies.